4//SEC Filing
Martin Robert Daniel 4
Accession 0000899243-18-007662
CIK 0001042418other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 8:15 PM ET
Size
7.8 KB
Accession
0000899243-18-007662
Insider Transaction Report
Form 4
Martin Robert Daniel
Director
Transactions
- Award
Common Stock Option
2018-03-13+253,000→ 253,000 totalExercise: $0.27From: 2019-03-13Exp: 2028-03-13→ Common Stock (253,000 underlying) - Award
Common Stock Option
2018-03-13+56,000→ 56,000 totalExercise: $0.27From: 2018-03-13Exp: 2028-03-13→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]These options were granted subject to the approval of the majority stockholder of the registrant pursuant to an agreement between the majority stockholder and the registrant. In the event that the majority stockholder does not approve the option grant, the options will be canceled.
Documents
Issuer
HedgePath Pharmaceuticals, Inc.
CIK 0001042418
Entity typeother
Related Parties
1- filerCIK 0001509322
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 8:15 PM ET
- Size
- 7.8 KB